Price to Book Value (P/BV)
since 2005
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Selected Financial Data since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Abbott Laboratories, P/BV, long-term trends, calculation
| P/BV | = | Share price1, 2, 3 | ÷ | Book value per share1 (BVPS) | BVPS1 | = | Total Abbott shareholders’ investment1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Abbott Laboratories Annual Report.
The price-to-book value (P/BV) ratio for the period examined exhibits considerable fluctuation. Initially, the ratio demonstrates an increasing trend from 2006 to 2007, peaking at 5.88. Subsequently, it declines through 2009, followed by a more pronounced drop to a low of 2.06 in 2013. A recovery is then observed, with the ratio generally increasing until 2021, reaching a high of 6.65. More recent years, 2022 through 2026, show a decreasing trend, though remaining above the levels seen in the early 2010s.
- Initial Period (2006-2007)
- The P/BV ratio increased from 4.69 to 5.88. This suggests a growing investor confidence in the company’s ability to generate value relative to its book value, or potentially an increase in market sentiment.
- Decline and Low Point (2008-2013)
- A period of decline is evident, culminating in a low of 2.06 in 2013. This decrease could be attributed to various factors, including broader economic conditions, industry-specific challenges, or company-specific performance issues impacting investor perception of the company’s value. The global financial crisis during this period likely contributed to this downward trend.
- Recovery and Peak (2014-2021)
- From 2014 onwards, the P/BV ratio generally increased, reaching 6.65 in 2021. This indicates a renewed investor confidence and a strengthening of the relationship between market price and book value. The growth in this period suggests improved financial performance and/or positive market expectations.
- Recent Trend (2022-2026)
- The most recent period shows a decreasing P/BV ratio, falling from 5.75 to 3.74. While still above the lows experienced in the early 2010s, this decline warrants attention. It could signal changing market conditions, increased investor caution, or concerns about future growth prospects. The ratio’s movement in 2025 and 2026 suggests a potential shift in investor valuation.
The book value per share (BVPS) generally increased over the period, although not consistently. The most significant increases occurred between 2009 and 2012, and again between 2019 and 2026. The fluctuations in the P/BV ratio are not solely driven by changes in share price, as the BVPS also contributes to the overall ratio. The divergence between share price and BVPS trends explains the observed P/BV ratio movements.
Overall, the P/BV ratio demonstrates a cyclical pattern, influenced by both market sentiment and underlying financial performance. The recent decline, while not reaching previous lows, suggests a need for further investigation into the factors driving this trend.
Comparison to Competitors
Abbott Laboratories, P/BV, long-term trends, comparison to competitors
| Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|
| Feb 20, 2026 | |||||
| Feb 21, 2025 | |||||
| Feb 16, 2024 | |||||
| Feb 17, 2023 | |||||
| Feb 18, 2022 | |||||
| Feb 19, 2021 | |||||
| Feb 21, 2020 | |||||
| Feb 22, 2019 | |||||
| Feb 16, 2018 | |||||
| Feb 17, 2017 | |||||
| Feb 19, 2016 | |||||
| Feb 27, 2015 | |||||
| Feb 21, 2014 | |||||
| Feb 15, 2013 | |||||
| Feb 21, 2012 | |||||
| Feb 18, 2011 | |||||
| Feb 19, 2010 | |||||
| Feb 20, 2009 | |||||
| Feb 19, 2008 | |||||
| Feb 23, 2007 | |||||
| Feb 22, 2006 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Abbott Laboratories, P/BV, long-term trends, comparison to sector (health care equipment & services)
| Abbott Laboratories | Health Care Equipment & Services | |
|---|---|---|
| Feb 20, 2026 | ||
| Feb 21, 2025 | ||
| Feb 16, 2024 | ||
| Feb 17, 2023 | ||
| Feb 18, 2022 | ||
| Feb 19, 2021 | ||
| Feb 21, 2020 | ||
| Feb 22, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 19, 2016 | ||
| Feb 27, 2015 | ||
| Feb 21, 2014 | ||
| Feb 15, 2013 | ||
| Feb 21, 2012 | ||
| Feb 18, 2011 | ||
| Feb 19, 2010 | ||
| Feb 20, 2009 | ||
| Feb 19, 2008 | ||
| Feb 23, 2007 | ||
| Feb 22, 2006 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Abbott Laboratories, P/BV, long-term trends, comparison to industry (health care)
| Abbott Laboratories | Health Care | |
|---|---|---|
| Feb 20, 2026 | ||
| Feb 21, 2025 | ||
| Feb 16, 2024 | ||
| Feb 17, 2023 | ||
| Feb 18, 2022 | ||
| Feb 19, 2021 | ||
| Feb 21, 2020 | ||
| Feb 22, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 19, 2016 | ||
| Feb 27, 2015 | ||
| Feb 21, 2014 | ||
| Feb 15, 2013 | ||
| Feb 21, 2012 | ||
| Feb 18, 2011 | ||
| Feb 19, 2010 | ||
| Feb 20, 2009 | ||
| Feb 19, 2008 | ||
| Feb 23, 2007 | ||
| Feb 22, 2006 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).